In vitro activity of meropenem against organisms causing serious infections in a Singapore hospital

International Journal of Antimicrobial Agents

Volumn 9, Issue 2, 1997, Pages 121-125

  Kumarasinghe, G ^a   Chow, C ^a   Chiu, C ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

In vitro; Meropenem; Nosocomial infections

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CARBAPENEM DERIVATIVE; CEFOPERAZONE; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; MEROPENEM; METICILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN; SULBACTAM; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEROIDES; BURKHOLDERIA PSEUDOMALLEI; CITROBACTER; CONTROLLED STUDY; ENTEROBACTER; ESCHERICHIA COLI; HOSPITAL INFECTION; IN VITRO STUDY; KLEBSIELLA; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; SINGAPORE; STAPHYLOCOCCUS AUREUS;

EID: 0030866831     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(97)00036-8     Document Type: Article

References (9)

1. Edwards JR, Turner PJ, Wannop C, Withnell ES, Grindey AJ, Nairn K. In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase-I. Antimicrob Agents Chemother 1989;33(2):215-22.
2. Edwards JR, Turner PJ. Laboratory data which differentiate meropenem and imipenem. Scand J Infect Dis 1995;Suppl 96:5-10.
3. Kumarasinghe G, Chow C, Koh KL, Chiang KL, Liew HY, Ti TY. Antimicrobial resistance problems in a University Hospital. Pathology 1995;27:67-70.
4. Inglis TJJ, Kumarasinghe G, Chow C, Liew HY. Multiple antibiotic resistance in Klebsiella spp. and other Enterbacteriaceae isolated in Singapore. Singapore Med J 1994;35:602-4.
5. Wiseman LR, et al. Focus on meropenem. Drugs 1995;50(1):73-101.
6. Edwards JR. Meropenem: a microbiological overview. J Antimicrob Chemother 1995;36(Suppl A):1-17.
7. White NJ, Dance DAB, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchata N. Halving of mortality of severe melioidosis by ceftazidime. Lancet 1989;8665(2):697-700.
8. Neu HC. Why carbapenems. Curr Opin Infect Dis 1994;7(Suppl 1):S3-10.
9. Mett H, Rosta S, Schacher B. Outer membrane permeability and β-lactamase content in Pseudomonas maltophilia in clinical isolates and laboratory mutants. Rev Infect Dis 1988;10(H):765-9.